Healthcare is a top priority for China.
Hospitals in the country treat tens of millions of patients every day with high-quality and affordable care, all thanks to one of the world's most robust health industries.
It's the largest producer of Active Pharmaceutical Ingredients (API), the biggest exporter of medical devices and a world leader in clinical trial registrations.
But now, the country is taking its health industry to another level.
China's southern economic powerhouse, Guangdong, has vowed to boost bio-pharmaceutical and health industry into a one trillion RMB business by 2027, according to its latest action plan.
This is great news for everyone involved in the healthcare market—investors, researchers, and, most importantly, the patients.
How does the latest action plan show China's ambition to boost its biopharma sector? This episode of News Xplained finds out.
Reporter: Xachary
Cameraman: Leo
Video: Xachary
Editor: Nina, Steven
